These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29602706)

  • 1. Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    Liu J; Jackson K; Weinkauf J; Kapasi A; Hirji A; Meyer S; Mullen J; Nagendran J; Lien D; Halloran K
    J Heart Lung Transplant; 2018 Jul; 37(7):895-902. PubMed ID: 29602706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline lung allograft dysfunction after bilateral deceased-donor lung transplantation: A single-center experience in Japan.
    Yamaguchi M; Kawashima M; Muraoka T; Yamaya T; Cong Y; Nakao K; Nagano M; Konoeda C; Kage H; Sato M
    Respir Investig; 2024 Sep; 62(5):838-843. PubMed ID: 39047315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Baseline Lung Allograft Dysfunction in Single Lung Transplant Recipients.
    Gerckens M; Mümmler C; Richard A; Strodel J; Mertsch P; Milger K; Veit T; Gade N; Yildirim AÖ; Schneider C; Kauke T; Michel S; Irlbeck M; Behr J; Kneidinger N
    Transplantation; 2024 Sep; ():. PubMed ID: 39250332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation.
    Li D; Weinkauf J; Kapasi A; Hirji A; Varughese R; Lien D; Nagendran J; Halloran K
    Respir Med; 2021 Nov; 188():106617. PubMed ID: 34571454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.
    Keller MB; Sun J; Alnababteh M; Ponor L; D Shah P; Mathew J; Kong H; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Kyoo Jang M; Agbor-Enoh S
    Transplant Direct; 2024 Jul; 10(7):e1669. PubMed ID: 38953039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway oscillometry parameters in baseline lung allograft dysfunction: Associations from a multicenter study.
    Darley DR; Nilsen K; Vazirani J; Borg BM; Levvey B; Snell G; Plit ML; Tonga KO
    J Heart Lung Transplant; 2023 Jun; 42(6):767-777. PubMed ID: 36681528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients.
    Kao JE; Zirbes JM; Conrad CK; Milla CE
    J Heart Lung Transplant; 2017 Sep; 36(9):980-984. PubMed ID: 28651906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor Smoking and Older Age Increases Morbidity and Mortality After Lung Transplantation.
    Schultz HH; Møller CH; Zemtsovski M; Ravn J; Perch M; Martinussen T; Carlsen J; Iversen M
    Transplant Proc; 2017 Nov; 49(9):2161-2168. PubMed ID: 29149977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Time to Peak Values for Different Lung Function Parameters After Double Lung Transplantation.
    Lawaetz Schultz HH; Møller CH; Møller-Sørensen H; Mortensen J; Lund TK; Andersen CB; Perch M; Carlsen J; Iversen M
    Transplant Proc; 2020; 52(1):295-301. PubMed ID: 31911058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor smoking and substance use on post-lung transplant outcomes.
    Rappaport JM; Siddiqui HU; Thuita L; Budev M; McCurry KR; Blackstone EH; Ahmad U;
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):383-393.e13. PubMed ID: 36967372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.
    Belloli EA; Wang X; Murray S; Forrester G; Weyhing A; Lin J; Ojo T; Lama VN
    Am J Respir Crit Care Med; 2015 Jul; 192(2):209-18. PubMed ID: 25922973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
    Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atelectasis in primary graft dysfunction survivors after lung transplantation.
    Li D; Abele J; Weinkauf J; Kapasi A; Hirji A; Varughese R; Nagendran J; Lien D; Doucette K; Halloran K
    Clin Transplant; 2021 Jul; 35(7):e14315. PubMed ID: 33848359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.